EFFECTOR Therapeutics Analysis
EFFECTOR Therapeutics is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of EFFECTOR Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what EFFECTOR Therapeutics is worth, separate from its market price. There are two main types of EFFECTOR Therapeutics' stock analysis: fundamental analysis and technical analysis.
The EFFECTOR Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
EFFECTOR |
EFFECTOR Pink Sheet Analysis Notes
The company recorded a loss per share of 0.91. EFFECTOR Therapeutics had not issued any dividends in recent years. The quote for EFFECTOR Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about EFFECTOR Therapeutics call Stephen Worland at 858 925 8215 or check out https://effector.com.EFFECTOR Therapeutics Investment Alerts
| EFFECTOR Therapeutics is not yet fully synchronised with the market data | |
| EFFECTOR Therapeutics has some characteristics of a very speculative penny stock | |
| EFFECTOR Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (35.81 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| EFFECTOR Therapeutics generates negative cash flow from operations |
EFFECTOR Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EFFECTOR Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on EFFECTOR Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EFFECTOR Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Presidio Management Group X Llc over six months ago Disposition of 799 shares by Presidio Management Group X Llc of EFFECTOR Therapeutics at 6.695 subject to Rule 16b-3 | ||
Byrnes Michael over six months ago Acquisition by Byrnes Michael of 4524 shares of EFFECTOR Therapeutics at 0.4973 subject to Rule 16b-3 | ||
Ehrlich Christopher B over six months ago Acquisition by Ehrlich Christopher B of 18867 shares of EFFECTOR Therapeutics at 0.55 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Disposition of 33799 shares by Stephen Worland of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Acquisition by Stephen Worland of 33799 shares of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding EFFECTOR Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in EFFECTOR Pink Sheet
If you are still planning to invest in EFFECTOR Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EFFECTOR Therapeutics' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |